Table 2 Correlation between LINC00326 expression and clinicopathological features in 96 NSCLC patients
Parameters | Group | N | Expression of LINC00326 | P value | |
|---|---|---|---|---|---|
Low, n (%) | High, n (%) | ||||
Age (years) | ≤ 58 | 47 | 24 (51.06) | 23 (48.94) | 0.4205 |
> 58 | 49 | 21 (42.86) | 28 (57.14) | ||
Gender | Female | 48 | 22 (45.83) | 26 (54.17) | 0.8379 |
Male | 48 | 23 (47.92) | 25 (52.08) | ||
Tumor size (cm) | < 3 | 45 | 18 (40.00) | 27 (60.00) | 0.1447 |
≥ 3 | 51 | 28 (54.90) | 23 (45.10) | ||
TNM stage | I–II | 49 | 18 (36.73) | 31 (63.27) | 0.0021 |
III–IV | 47 | 32 (68.09) | 15 (31.91) | ||
Smoking history | Yes | 53 | 24 (45.28) | 29 (54.72) | 0.7286 |
No | 43 | 21 (48.84) | 22 (51.16) | ||
Lymph node metastasis | Yes | 50 | 33 (66.00) | 17 (34.00) | 0.0022 |
No | 46 | 16 (34.78) | 30 (65.22) | ||
Differentiation | Well/moderate | 49 | 13(26.53) | 36(73.47) | 0.0076 |
Poor | 47 | 25(53.19) | 22(46.81) | ||